NCT06474078View on ClinicalTrials.gov

Study To Evaluate The Efficacy Of Tofacitinib In Patients With SJS/TEN

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

June 20, 2025

Study Completion Date

June 20, 2025

Conditions
Stevens-Johnson SyndromeToxic Epidermal Necrolysis
Interventions
DRUG

Tofacitinib

Dosage/Frequency: 5mg - 10mg, oral, twice daily

Trial Locations (1)

333

Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER